114 related articles for article (PubMed ID: 15744637)
1. Depression during therapy with interferon alpha--how long should an antidepressant treatment last?
Nickel T; Sonntag A; Backmund M; Pollmächer T
Pharmacopsychiatry; 2005 Mar; 38(2):102-4. PubMed ID: 15744637
[TBL] [Abstract][Full Text] [Related]
2. [Reflections on the treatment of EDM in hepatitis C virus patients treated with interferon alpha from a retrospective survey concerning 29 patients].
Lang JP; Halleguen O; Vecchionacci V; Doffoel M
Encephale; 2003; 29(3 Pt 1):273-7. PubMed ID: 12876553
[TBL] [Abstract][Full Text] [Related]
3. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.
Hauser P
Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S35-50. PubMed ID: 15081102
[TBL] [Abstract][Full Text] [Related]
5. First report of mirtazapine overdose.
Hoes MJ; Zeijpveld JH
Int Clin Psychopharmacol; 1996 Jun; 11(2):147. PubMed ID: 8803652
[TBL] [Abstract][Full Text] [Related]
6. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
Kalyoncu OA; Tan D; Mirsal H; Pektas O; Beyazyurek M
J Psychopharmacol; 2005 Jan; 19(1):102-5. PubMed ID: 15671136
[TBL] [Abstract][Full Text] [Related]
7. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
[TBL] [Abstract][Full Text] [Related]
8. Mirtazapine for the treatment of interferon-induced psychopathology.
Russo S; Boon JC; Korf J; Haagsma EB
Gen Hosp Psychiatry; 2003; 25(6):497. PubMed ID: 14706418
[No Abstract] [Full Text] [Related]
9. Effects of antidepressant mirtazapine on fibromyalgia symptoms.
Samborski W; Lezańska-Szpera M; Rybakowski JK
Rocz Akad Med Bialymst; 2004; 49():265-9. PubMed ID: 15631355
[TBL] [Abstract][Full Text] [Related]
10. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
11. Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment.
Beratis S; Katrivanou A; Georgiou S; Monastirli A; Pasmatzi E; Gourzis P; Tsambaos D
J Psychosom Res; 2005 Jan; 58(1):15-8. PubMed ID: 15771865
[TBL] [Abstract][Full Text] [Related]
12. Chronic paranoid psychosis and dementia following interferon-alpha treatment of hepatitis C: a case report.
Drozdz W; Borkowska A; Wilkosc M; Halota W; Dybowska D; Rybakowski JK
Pharmacopsychiatry; 2007 Jul; 40(4):146-8. PubMed ID: 17694476
[TBL] [Abstract][Full Text] [Related]
13. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
[TBL] [Abstract][Full Text] [Related]
14. Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion.
Jagsch C; Marksteiner J; Seiringer E; Windhager E
Pharmacopsychiatry; 2007 May; 40(3):129-31. PubMed ID: 17541890
[TBL] [Abstract][Full Text] [Related]
15. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study.
Yoon SJ; Pae CU; Kim DJ; Namkoong K; Lee E; Oh DY; Lee YS; Shin DH; Jeong YC; Kim JH; Choi SB; Hwang IB; Shin YC; Cho SN; Lee HK; Lee CT
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1196-201. PubMed ID: 16624467
[TBL] [Abstract][Full Text] [Related]
16. Can prefrontal theta cordance differentiate between depression recovery and dissimulation?
Kopecek M; Sos P; Brunovsky M; Bares M; Stopkova P; Krajca V
Neuro Endocrinol Lett; 2007 Aug; 28(4):524-6. PubMed ID: 17693989
[TBL] [Abstract][Full Text] [Related]
17. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
Russo S; Kema IP; Haagsma EB; Boon JC; Willemse PH; den Boer JA; de Vries EG; Korf J
Psychosom Med; 2005; 67(5):773-7. PubMed ID: 16204437
[TBL] [Abstract][Full Text] [Related]
18. Migraine headache prophylaxis and treatment with low-dose mirtazapine.
Lévy E; Margolese HC
Int Clin Psychopharmacol; 2003 Sep; 18(5):301-3. PubMed ID: 12920393
[TBL] [Abstract][Full Text] [Related]
19. Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C.
Raison CL; Woolwine BJ; Demetrashvili MF; Borisov AS; Weinreib R; Staab JP; Zajecka JM; Bruno CJ; Henderson MA; Reinus JF; Evans DL; Asnis GM; Miller AH
Aliment Pharmacol Ther; 2007 May; 25(10):1163-74. PubMed ID: 17451562
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G
Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
